Proteomics in Uveal Melanoma

Peer-Reviewed
Analysis of proteins in blood and ocular fluids may provide new opportunities for diagnosis, prognostication, and therapeutic discovery.

By Arun D. Singh, MD, Kevin Allan, MD, PhD

Evolving Treatment Strategies for Noninfectious Uveitis

Advances in corticosteroid delivery, systemic immunomodulation, and pipeline therapies are expanding options for individualized management.

By William R. Bloom, MD, Ana M. Suelves, MD, PhD

Genetic Testing in Retinoblastoma: New Applications

Liquid biopsy and molecular profiling are expanding the diagnostic and prognostic role of genetic testing in retinoblastoma.

By Soumaya Bouhout, MD, Arun D. Singh, MD

JIA-Associated Uveitis in Adults

Ophthalmologists caring for adults with this condition may encounter persistent inflammation, treatment dependence, and the cumulative ocular effects of childhood disease.

By Alissa Belzie, MD, MS, Ana M. Suelves, MD, PhD

Strategies to Prevent Radiation Retinopathy

A review of established and investigational approaches to reducing vision-threatening complications after plaque brachytherapy.

By Hannah Hongan Chen, MD, Arun D. Singh, MD

Optimizing Corticosteroid Therapy in Uveitis

Practical strategies for integrating injectable corticosteroids into the treatment of noninfectious ocular inflammation.

By Howard F. Fine, MD

Updates in Uveitis and Ocular Oncology

Upfront
The September/October issue has a focus on ocular oncology and uveitis.

By Diana V. Do, MD

Revakinagene for MacTel: Is the Benefit Worth the Cost?

Controversies in Care
Examining the clinical benefits and economic implications of encapsulated cell therapy

By Michael Colucciello, MD, Martin Friedlander, MD, PhD, Kristin Raming, MD

Coding for Ocular Tumors

Coding Q&A
Distinguishing among tumor types is critical to accurate coding.

By Elizabeth Cifers, MBA, MSW, CHC, CPC

Clinical Trial Update September/October 2026

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

Comanagement Strategies in GA Care: Understanding the Patient's GA Journey

From the OD to the retina specialist, consistent messaging is key

By Damon Dierker, OD, FAAO, Ankur M. Shah, MD, FASRS